QYQuan Yang

Quan Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Quan Yang has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Zhou

    Tianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China

    7 shared publications
  • Jun Huang

    Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, China

    7 shared publications
  • Lu Zhou

    State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology The Second Affiliated Hospital, Guangzhou Medical University Guangzhou China

    6 shared publications
  • Yanwei Qi

    Department of Pathogenic Biology and Immunology, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China

    6 shared publications
  • Yi Zhao

    Department of Pathogenic Biology and Immunology, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China

    6 shared publications
  • Yiqiang Zhu

    State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou China

    6 shared publications

Latest Publications

  • Circ_0004801 promotes tau hyperphosphorylation and cognitive impairment in Alzheimer's disease through the miR-7688-5p/TTBK1 axis

    by Qingqing Li, Jie Xiao, Guorong Deng, Huajie Zhong, Yahan Li, Weicheng Lin, Minhui Zhou, YiShuai Lu, Chao Huang, Chengyin Wang, et al.

    Background: Abnormal tau hyperphosphorylation is a central feature of Alzheimer's disease (AD). Tau tubulin kinase 1 (TTBK1) is a key kinase involved in tau phosphorylation, but its upstream regulatory mechanisms remain poorly understood. Objective: To identify circRNAs involved in the upstream regulation of TTBK1 and elucidate their molecular mechanisms and functional roles in tau hyperphosphorylation and cognitive impairment in AD. Methods: Hippocampal circRNA and miRNA profiles were analyzed in 6-month-old 3×Tg-AD and wild-type mice. The candidate regulatory axis was investigated using qRT-PCR, Western blotting, dual-luciferase reporter and RNA immunoprecipitation assays, cell viability and apoptosis analyses, lentiviral intervention, immunofluorescence, silver staining, and behavioral tests. Results: Circ_0004801 was upregulated and miR-7688-5p was downregulated in the hippocampus of 3×Tg-AD mice. Circ_0004801 knockdown enhanced HT22 cell viability, reduced apoptosis, decreased TTBK1 expression, and suppressed tau phosphorylation at Ser199, Ser202, and Ser396. MiR-7688-5p overexpression reduced TTBK1 expression and tau phosphorylation at Ser199 and Ser202, whereas TTBK1 overexpression reversed these effects. Reporter and RNA immunoprecipitation assays supported a sequence-dependent interaction between circ_0004801 and miR-7688-5p and their association with the Ago2 complex. In vivo, circ_0004801 knockdown reduced hippocampal p-tau (Ser199) and improved spatial learning, memory, and object recognition, whereas TTBK1 overexpression attenuated these benefits. Conclusions: Circ_0004801 acts as an upstream regulator of TTBK1 by sequestering miR-7688-5p, thereby promoting tau hyperphosphorylation and cognitive impairment in AD. This axis may represent a potential target for tau-directed intervention.

  • Open Access

    Plasmodium yoelii infection induces lung injury by modulating type 2 conventional dendritic cells autophagy via the STAT3-IRF4 signaling

    by Cansheng Hong, Guorong Deng, Zhihan Jiang, Yishuai Lu, Qianlian Wu, Chao Huang, Jia Tang, Haiqi Zhou, Qinan Liu, Xiujuan Luo, et al.

    Malaria is an infectious disease caused by Plasmodium that severely impacts human health, often resulting in lung injury. Classical type 2 dendritic cells (cDC2) in the lungs play a crucial role in the pathogenesis of asthma and infectious diseases; however, their specific functions during Plasmodium infection remain poorly understood. In this study, we demonstrated a significant accumulation and activation of cDC2 in the lungs of mice infected with Plasmodium . While the phagocytosis ability of activated cDC2 decreases, it promotes the differentiation of CD4 + T cells towards Th1 cells, thereby exacerbating lung injury. During our investigation into cDC2 accumulation in the lungs, we discovered that this accumulation may occur through autophagy. Furthermore, mechanistic studies revealed that the effect of Plasmodium on cDC2 is mediated by the JAK/STAT3 signaling pathway. Inhibition of STAT3 phosphorylation by the JAK inhibitor JSI-124 almost completely abolished the influence of Plasmodium on cDC2. The role of cDC2 in lung injury induced by Plasmodium infection was further substantiated in IRF4-deficient mice infected with Plasmodium . In conclusion, our research significantly enriches our understanding of lung cDC2, further elucidates the pathogenic mechanisms of Plasmodium infection, and offers a novel theoretical foundation for malaria prevention and control.

  • Plasmodium yoelii infection regulates M1 macrophage polarization and function through TLR7/STAT3 signaling pathway

    by Lengshan Mo, Zhihan Jiang, Cansheng Hong, Jia Guo, Guochang Qiu, Qianlian Wu, Guorong Deng, Yujie Chen, Yishuai Lu, Haiqi Zhou, et al.


  • Myeloid‐derived suppressor cells inhibit responses of T follicular helper cells during experimental Plasmodium yoelii infection

    by Lengshan Mo, Cansheng Hong, Zhihan Jiang, Yiqiang Zhu, Lu Zhou, Simin Tan, Guorong Deng, Yanwei Qi, Tengfei Hu, Qianlian Wu, et al.

    Malaria remains a significant global public health problem. T follicular helper (Tfh) cells, a subset of CD4 + T cells, have the capacity to regulate B cells, plasma cells, and antibody production, among other functions. Myeloid‐derived suppressor cells (MDSCs) possess strong immunosuppressive abilities and can negatively regulate various immune responses. However, the role of MDSCs in inhibiting Tfh‐cell responses during Plasmodium infection remains unclear. In this study, we investigated the regulatory effect of MDSCs on Tfh cell‐mediated immune responses upon Plasmodium infection. We found that the numbers of MDSCs increased upon Plasmodium infection. Further mechanism study revealed that MDSC‐derived Arg‐1 and PD‐L1 prevented Tfh cell proliferation and activation. Conversely, the addition of nor‐NOHA or anti‐PD‐L1 monoclonal antibodies enhanced the proliferation and activation of Tfh cells, indicating that the inhibitory effect of MDSCs on Tfh cells was dependent on Arg‐1 and PD‐1/PD‐L1. In vivo depletion of MDSCs enhanced Tfh‐cell responses and antibody production, as well as relieved symptoms of infected mice and improved their survival rates. These findings provide insights into the immunosuppressive role of MDSCs in inhibiting Tfh cell immune responses and further impairing humoral immunity. Our study provides new strategies for malaria prevention and control.


  • Open Access

    IRF4 regulates myeloid-derived suppressor cells expansion and function in Schistosoma japonicum-infected mice

    by Lu Zhou, Peibin Lin, Guorong Deng, Lengshan Mo, Cansheng Hong, Zhihan Jiang, Yiqiang Zhu, Yi Zhao, Yanwei Qi, Tengfei Hu, et al.

    Background: Interferon regulatory factor 4 (IRF4) is a crucial member of the IRF family of transcription factors and is pivotal in orchestrating the body’s defense against tumors and infections by modulating the differentiation and functionality of immune cells. The role of IRF4 in mice during Schistosoma japonicum infection, as well as the effects of IRF4 deficiency on myeloid-derived suppressor cells (MDSCs), remains inadequately understood. Methods: Hematoxylin and eosin staining was used to evaluate the pathological damage in different organs of mice following infection with S. japonicum. Flow cytometry was employed to study the effect of IRF4 on the proliferation and function of myeloid-derived suppressor cells (MDSCs) in S. japonicum-infected mice. Results: Knockout of IRF4 in myeloid cells significantly mitigated pathological damage to the liver and lungs in mice infected with S. japonicum. Knockout of IRF4 in myeloid cells also inhibited the expansion and functionality of MDSCs by downregulating programmed death ligand 2 (PD-L2) expression and interleukin-1 alpha (IL-1α) secretion in mice infected with S. japonicum. Mechanistic studies revealed that IRF4 deficiency inhibited the expansion and function of MDSCs and that this inhibition was mediated by the STAT3 and AKT signaling pathways. Also, IRF4 myeloid knockout promoted the expansion of T cells in S. japonicum-infected mice, but had no significant effect on B cell aggregation. Conclusions: Overall, these findings highlight the importance of IRF4 in regulating MDSCs and their impact on tissue damage during S. japonicum infection, providing valuable insights into potential therapeutic targets for managing the pathological consequences of this parasitic infection. Graphical


  • Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway

    by Yiqiang Zhu, Lu Zhou, Lengshan Mo, Cansheng Hong, Lingxia Pan, Jie Lin, Yanwei Qi, Simin Tan, Manhongtian Qian, Tengfei Hu, et al.

    Myeloid-derived suppressor cells (MDSCs), the negative immune regulators, have been demonstrated to be involved in immune responses to a variety of pathological conditions, such as tumors, chronic inflammation, and infectious diseases. However, the roles and mechanisms underlying the expansion of MDSCs in malaria remain unclear. In this study, the phenotypic and functional characteristics of splenic MDSCs during Plasmodium yoelii NSM infection are described. Furthermore, we provide compelling evidence that the sera from P. yoelii–infected C57BL/6 mice containing excess IL-6 and granulocyte-macrophage colony-stimulating factor promote the accumulation of MDSCs by inducing Bcl2 expression. Serum-induced MDSCs exert more potent suppressive effects on T cell responses than control MDSCs within both in vivo P. yoelii infection and in vitro serum-treated bone marrow cells experiments. Serum treatment increases the MDSC inhibitory effect, which is dependent on Arg1 expression. Moreover, mechanistic studies reveal that the serum effects are mediated by JAK/STAT3 signaling. By inhibiting STAT3 phosphorylation with the JAK inhibitor JSI-124, effects of serum on MDSCs are almost eliminated. In vivo depletion of MDSCs with anti–Gr-1 or 5-fluorouracil significantly reduces the parasitemia and promotes Th1 immune response in P. yoelii–infected C57BL/6 mice by upregulating IFN-γ expression. In summary, this study indicates that P. yoelii infection facilitates the accumulation and function of MDSCs by upregulating the expression of Bcl2 and Arg1 via JAK/STAT3 signaling pathway in vivo and in vitro. Manipulating the JAK/STAT3 signaling pathway or depleting MDSCs could be promising therapeutic interventions to treat malaria.


  • Open Access

    β‐Glucan Subverts the Function of Myeloid Cells in Neonates

    by Yingying Chen, Hui Li, Lin Zhu, Quan Yang, Jie Zhou

    β‐Glucan is the main component of the cell wall of pathogen‐associated molecular patterns (PAMPs) including various yeast, fungi, or certain bacteria. Previous reports demonstrated that β‐glucan was widely investigated as a potent immunomodulators to stimulate innate and adaptive immune responses, which indicated that it could be recommended as an effective adjuvant in immunotherapy. However, the detailed effects of β‐glucan on neonatal immunity are still largely unknown. Here, we found that β‐glucan did not affect the frequencies and numbers of myeloid cells in the spleen and bone marrow from neonates. Functional assay revealed that β‐glucan from neonates compromised the immunosuppressive function of immature myeloid cells, which were myeloid‐derived suppressor cells (MDSCs). Flow cytometry or gene expression analysis revealed that β‐glucan‐derived polymorphonuclear (PMN)‐MDSCs produced lower level of reactive oxygen species (ROS) and arginase‐1 (Arg1) in neonatal mice. Furthermore, β‐glucan administration significantly decreased the frequency and ROS level of PMN‐MDSCs in vitro. These observations suggest that β‐glucan facilitates the maturation of myeloid cells in early life, which may contribute to its beneficial effects against immune disorders later in life.


  • TLR7 enhancing follicular helper T (Tfh) cells response in C57BL/6 mice infected with Plasmodium yoeliiNSM TLR7 mediated Tfh cells in P. yoelii infected mice

    by Quan Yang, Lu Zhou, Zhengrong Tan, Yiqiang Zhu, Lengshan Mo, Chao Fang, Jiajie Li, Chen Chen, Ying Luo, Haixia Wei, et al.

    Toll‐like receptors (TLRs) play an important role in inducing innate and acquired immune responses against infection. However, the effect of Toll‐like receptor 7 (TLR7) on follicular helper T (Tfh) cells in mice infected with Plasmodium is still not clear. The results showed that the splenic CD4+CXCR5+PD‐1+ Tfh cells were accumulated after Plasmodium yoelii NSM infection, the content of splenic Tfh cells was correlated to parasitemia and/or the red blood cells (RBCs) counts in the blood. Moreover, the expression of TLR7 was found higher than TLR2, TLR3 and TLR4 in splenic Tfh cells of the WT mice. TLR7 agonist R848 and the lysate of red blood cells of infected mice (iRBCs) could induce the activation and differentiation of splenic Tfh cells. Knockout of TLR7 leads to a decrease in the proportion of Tfh cells, down‐regulated expression of functional molecules CD40L, IFN‐γ, IL‐21 and IL‐10 in Tfh cells; decreased the proportion of plasma cells and antibody production and reduces the expression of STAT3 and Ikzf2 in Tfh cells. Administration of R848 could inhibit parasitemia, enhance splenic Tfh cell activation and increase STAT3 and Ikzf2 expression in Tfh cells. In summary, this study shows that TLR7 could regulate the function of Tfh cells, affecting the immune response in the spleen of Plasmodium yoelii NSM‐infected mice.


  • Open Access

    TLR7 controls myeloid-derived suppressor cells expansion and function in the lung of C57BL6 mice infected with Schistosoma japonicum

    by Lu Zhou, Yiqiang Zhu, Lengshan Mo, Mei Wang, Jie Lin, Yi Zhao, Yuanfa Feng, Anqi Xie, Haixia Wei, Huaina Qiu, et al.

    Toll-like receptors (TLRs) play an important role in the induction of innate and adaptive immune responses against Schistosoma japonicum (S. japonicum) infection. However, the role of Toll-like receptor 7 (TLR7) in the mouse lung during S. japonicum infection and the myeloid-derived suppressor cells (MDSCs) affected by the absence of TLR7 are not clearly understood. In this study, the results indicated that the MDSCs were accumulated and the proportion and activation of CD4+ and CD8+ T cells were decreased in the lung of mice at 6–7 weeks after S. japonicum infection. Then, the expression of TLR7 was detected in isolated pulmonary MDSCs and the results showed that the expression of TLR7 in MDSCs was increased after infection. Furthermore, TLR7 agonist R848 could down-regulate the induction effect of the soluble egg antigen (SEA) on pulmonary MDSCs in vitro. Meanwhile, TLR7 deficiency could promote the pulmonary MDSCs expansion and function by up-regulating the expression of PD-L1/2 and secreting of IL-10 in the mice infected with S. japonicum. Mechanistic studies revealed that S. japonicum infection and the antigen effects are mediated by NF-κB signaling. Moreover, TLR7 deficiency aggravates S. japonicum infection-induced damage in the lung, with more inflammatory cells infiltration, interstitial dilatation and granuloma in the tissue. In summary, this study indicated that TLR7 signaling inhibits the accumulation and function of MDSCs in S. japonicum infected mouse lung by down-regulating the expression of PD-L1/2 and secreting of IL-10, via NF-κB signaling.


  • Open Access

    Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation

    by Gaoyu Liu, Yingying Chen, Ying Wang, Xiaohui Deng, Qiang Xiao, Lijuan Zhang, Haixu Xu, Xu Han, Aihua Lei, Juan He, et al.

    Group 2 innate lymphoid cells (ILC2s) have emerged as critical mediators in driving allergic airway inflammation. Here, we identified angiotensin (Ang) II as a positive regulator of ILC2s. ILC2s expressed higher levels of the Ang II receptor AT1a, and colocalized with lung epithelial cells expressing angiotensinogen. Administration of Ang II significantly enhanced ILC2 responses both in vivo and in vitro, which were almost completely abrogated in AT1a-deficient mice. Deletion of AT1a or pharmacological inhibition of the Ang II–AT1 axis resulted in a remarkable remission of airway inflammation. The regulation of ILC2s by Ang II was cell intrinsic and dependent on interleukin (IL)-33, and was associated with marked changes in transcriptional profiling and up-regulation of ERK1/2 phosphorylation. Furthermore, higher levels of plasma Ang II correlated positively with the abundance of circulating ILC2s as well as disease severity in asthmatic patients. These observations reveal a critical role for Ang II in regulating ILC2 responses and airway inflammation.